Abstract:In a consecutive hospital-based autopsy series, we examined the relationship between apolipoprotein E (apoE) and Alzheimer's disease (AD) and investigated the clinicopathological relationship in AD. The study population included 99 patients (mean age 81 years) with AD-related neuropathological findings at death, of whom 83 were diagnosed with AD according to the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) classification, and a control group of patients without neurodegenerative disease (n = 1429). The patients were apoE genotyped and the density of β-amyloid senile plaques, neuritic plaques and neurofibrillary tangles was estimated in the cortex and hippocampus. The utility of immunohistochemical staining using an antibody directed against apoE4 in paraffin-embedded tissue was also evaluated. Among patients with "definite AD" according to CERAD, 65 % were ε4 carriers, compared to 32 % among controls (p < 0.001). The risk of ε4 carriers to develop AD was higher (odds ratio = 4.65, p = 0.001) than for non-ε4 carriers. The amount of β-amyloid deposition and neurofibrillary pathology differed significantly (p < 0.01) between the genotypes, with increasing densities from ε2 carriers to homozygous ε4 carriers. The effect of ε4 on the presence of clinical symptoms was attenuated and non-significant after adjusting for AD-related neuropathological findings. There was an association between these findings and the presence of clinical symptoms of AD, with neurofibrillary tangles separating patients with and without symptoms of AD markedly better than β-amyloid. In addition, we found a strong relationship between genotype and immunohistochemical apoE4-staining intensity. In conclusion, this Scandinavian autopsy study shows that the apoE polymorphism is associated with the probability of AD and influences the deposition of β-amyloid and neurofibrillary pathology. Our findings suggest that the association between apoE and clinical manifestations of AD is mediated mainly through the neuropathological features of AD. Further, we found a relationship between AD-related findings and clinical symptoms of AD with neurofibrillary tangles associating most strongly with clinical symptoms. Finally, immunohistochemical staining in brain specimens is useful for determining ε4- or non-ε4-carrier status.

Expression of Apolipoprotein E in Alzheimer's Disease and Its Significance

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease

Relationship between apolipoprotein E gene polymorphism and sporadic Alzheimer's disease

Function of apolipoprotein E in Alzheimer disease

The Application Value of ApoE Gene Polymorphism in Alzheimer's Disease

Correlation between apolipoprotein E gene and Alzheimer's disease

A Meta-Analysis of Alzheimer's Disease's Relationship with Human ApoE Gene Variants.

Prevalence Of The Apolipoprotein E Epsilon 4 Allele In Amyloid Beta Positive Subjects Across The Spectrum Of Alzheimer'S Disease

P4-188: apolipoprotein e ε4 allele is associated with plasma amyloid beta transport: a population-based cross-sectional study

APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease

Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment

Gene Polymorphism in Apolipoprotein E and Presenilin-1 in Patients with Late-Onset Alzheimer's Disease.

The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.

Apolipoprotein E Genotype in Patients with Alzheimer'S Disease

Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's Disease

Apolipoprotein E in Alzheimer's Disease: Focus on Synaptic Function and Therapeutic Strategy

Effects of Apolipoprotein E Allele and Age in Alzheimer’s Disease and Mild Cognitive Impairment in a Memory Clinic Cohort in Beijing

Effect of genetic polymorphism on apolipoprotein E glycosylation and lipoproteins metabolism